Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Gut

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Irinotecan vs non‐irinotecan‐containing regimens

Overall survival ‐ Substitutive comparisons · people with advanced gastric cancer

Irinotecan showed no clear difference in overall survival ‐ Substitutive comparisons compared with non‐irinotecan‐containing regimens (moderate certainty).

1 finding from 1 review

Chemotherapy for advanced gastric cancer 2017 · Cochrane Headline outcomes only
HR 0.87 [0.75, 1]
6 studies · 826 participants
Moderate

Docetaxel vs non‐docetaxel‐containing regimens

Overall survival ‐ Substitutive comparisons · people with advanced gastric cancer

Docetaxel showed no clear difference in overall survival ‐ Substitutive comparisons compared with non‐docetaxel‐containing regimens (moderate certainty).

1 finding from 1 review

Chemotherapy for advanced gastric cancer 2017 · Cochrane Headline outcomes only
HR 1.05 [0.87, 1.27]
3 studies · 479 participants
Moderate